The store will not work correctly when cookies are disabled.
3-(2-Chlorophenyl)-4-((2-(methylthio)phenyhamino)-1H-pyrrole-2,5-dione
ID: ALA4860677
PubChem CID: 164614728
Max Phase: Preclinical
Molecular Formula: C17H13ClN2O2S
Molecular Weight: 344.82
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CSc1ccccc1NC1=C(c2ccccc2Cl)C(=O)NC1=O
Standard InChI: InChI=1S/C17H13ClN2O2S/c1-23-13-9-5-4-8-12(13)19-15-14(16(21)20-17(15)22)10-6-2-3-7-11(10)18/h2-9H,1H3,(H2,19,20,21,22)
Standard InChI Key: QOPMGOKMDUADMG-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
3.0944 -16.0168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9116 -16.0168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1659 -15.2401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5030 -14.7580 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8442 -15.2401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6699 -16.7151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8506 -16.6953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4256 -17.3938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8187 -18.1126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6412 -18.1286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0625 -17.4294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3911 -16.6785 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2044 -16.6781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6096 -17.3846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4221 -17.3845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8293 -16.6795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4179 -15.9730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6067 -15.9765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9435 -14.9887 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0669 -14.9879 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2000 -18.0917 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.3828 -18.0905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4588 -15.9781 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
6 1 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 2 0
5 20 2 0
14 21 1 0
21 22 1 0
7 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 344.82 | Molecular Weight (Monoisotopic): 344.0386 | AlogP: 3.54 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.71 | CX Basic pKa: ┄ | CX LogP: 3.18 | CX LogD: 3.18 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.66 | Np Likeness Score: -0.71 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |